Literature DB >> 22649009

Assessment of accuracy of identification of pathogenic yeasts in microbiology laboratories in the United kingdom.

Andrew M Borman1, Adrien Szekely, Michael D Palmer, Elizabeth M Johnson.   

Abstract

Rapid, accurate identification of yeast isolates from clinical samples has always been important given their innately variable antifungal susceptibility profiles. Recently, this has become paramount with the proposed introduction of species-specific interpretive breakpoints for MICs obtained in yeast antifungal susceptibility tests (M. A. Pfaller, D. Andes, D. J. Diekema, A. Espinel-Ingroff, D. Sheehan, and CLSI Subcommittee for Antifungal Susceptibility Testing, Drug Resist. Updat. 13:180-195, 2010). Here, we present the results of a 12-month evaluation of the accuracy of identifications that accompany yeast isolates submitted to the Mycology Reference Laboratory (United Kingdom) for either confirmation of identity or susceptibility testing. In total, 1,781 yeast isolates were analyzed, and the robustness of prior identifications obtained in microbiology laboratories throughout the United Kingdom was assessed using a combination of culture on chromogenic agar, morphology on cornmeal agar, and molecular identification by pyrosequencing. Over 40% of isolates (755) were submitted without any suggested identification. Of those isolates with a prior identification, 100 (9.7%) were incorrectly identified. Error rates ranged from 5.2% (for organisms submitted for antifungal susceptibility testing) to 18.2% (for organisms requiring confirmation of identity) and varied in a strictly species-specific manner. At least 50% of identification errors would be likely to affect interpretation of MIC data, with a possible impact on patient management. In addition, 2.3% of submitted cultures were found to contain mixtures of at least two yeast species. The vast majority of mixtures had gone undetected in the referring laboratory and would have impacted the interpretation of antifungal susceptibility profiles and patient management. Some of the more common misidentifications are discussed according to the identification method employed, with suggestions for avoiding such misinterpretations.

Entities:  

Mesh:

Year:  2012        PMID: 22649009      PMCID: PMC3421536          DOI: 10.1128/JCM.00913-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

Review 1.  Yeast identification in the clinical microbiology laboratory: phenotypical methods.

Authors:  A M Freydiere; R Guinet; P Boiron
Journal:  Med Mycol       Date:  2001-02       Impact factor: 4.076

2.  Comparison of a new chromogenic agar with the germ tube method for presumptive identification of Candida albicans.

Authors:  C K Campbell; A D Holmes; K G Davey; A Szekely; D W Warnock
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

Review 3.  Nosocomial Candida. Epidemiology, transmission, and prevention.

Authors:  W L Wright; R P Wenzel
Journal:  Infect Dis Clin North Am       Date:  1997-06       Impact factor: 5.982

4.  National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.

Authors:  M A Pfaller; R N Jones; S A Messer; M B Edmond; R P Wenzel
Journal:  Diagn Microbiol Infect Dis       Date:  1998-05       Impact factor: 2.803

Review 5.  Laboratory diagnosis of systemic fungal diseases.

Authors:  L D Gray; G D Roberts
Journal:  Infect Dis Clin North Am       Date:  1988-12       Impact factor: 5.982

6.  Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution.

Authors:  M A Pfaller; L Boyken; R J Hollis; J Kroeger; S A Messer; S Tendolkar; D J Diekema
Journal:  J Clin Microbiol       Date:  2010-12-15       Impact factor: 5.948

7.  International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe).

Authors:  M A Pfaller; R N Jones; G V Doern; A C Fluit; J Verhoef; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal:  Diagn Microbiol Infect Dis       Date:  1999-09       Impact factor: 2.803

8.  Comparative study of seven commercial yeast identification systems.

Authors:  P E Verweij; I M Breuker; A J Rijs; J F Meis
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

9.  Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens.

Authors:  C K Campbell; K G Davey; A D Holmes; A Szekely; D W Warnock
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 10.  Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy.

Authors:  J R Wingard
Journal:  Clin Infect Dis       Date:  1994-08       Impact factor: 9.079

View more
  5 in total

1.  Accuracy of species-level identification of yeast isolates from blood cultures from 10 university hospitals in South Korea by use of the matrix-assisted laser desorption ionization-time of flight mass spectrometry-based Vitek MS system.

Authors:  Eun Jeong Won; Jong Hee Shin; Kyungwon Lee; Mi-Na Kim; Hye Soo Lee; Yeon-Joon Park; Min Young Joo; Soo Hyun Kim; Myung Geun Shin; Soon Pal Suh; Dong Wook Ryang
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

2.  Visual analysis of DNA microarray data for accurate molecular identification of non-albicans Candida isolates from patients with candidemia episodes.

Authors:  Michela De Luca Ferrari; Mariângela Ribeiro Resende; Kanae Sakai; Yasunori Muraosa; Luzia Lyra; Tohru Gonoi; Yuzuru Mikami; Kenichiro Tominaga; Katsuhiko Kamei; Angelica Zaninelli Schreiber; Plinio Trabasso; Maria Luiza Moretti
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

3.  Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values.

Authors:  Mariana Castanheira; Shawn A Messer; Paul R Rhomberg; Rachel R Dietrich; Ronald N Jones; Michael A Pfaller
Journal:  Mycopathologia       Date:  2014-06-21       Impact factor: 2.574

4.  Concordance analysis between different methodologies used for identification of oral isolates of Candida species.

Authors:  Alejandra Zuluaga; Karen Arango-Bustamante; Diego H Caceres; Zilpa A Sánchez-Quitian; Verónica Velásquez; Beatriz L Gómez; Claudia M Parra-Giraldo; Natalia Maldonado; Luz E Cano; Catalina de Bedout; Raúl E Rivera
Journal:  Colomb Med (Cali)       Date:  2018-09-30

Review 5.  Application of Culture-Independent Rapid Diagnostic Tests in the Management of Invasive Candidiasis and Cryptococcosis.

Authors:  Michael A Pfaller
Journal:  J Fungi (Basel)       Date:  2015-08-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.